Jillian B. Thomsen Nektar Therapeutics (NKTR) insider trading activity

Jillian B. Thomsen is Chief Financial Officer of NEKTAR THERAPEUTICS. Currently has a direct ownership of 313,497 shares of NKTR, which is worth approximately $385,601. The most recent transaction as insider was on Feb 16, 2023, when has been sold 10,267 shares (Common Stock) at a price of $3.0 per share, resulting in proceeds of $30,801. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 313K

0% 3M change

0% 12M change

Total Value Held $385,601

Jillian B. Thomsen Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 16 2023	SELL Open market or private sale	$30,801 $3.0 p/Share	10,267 Reduced 3.17%	313,497 Common Stock
Nov 16 2022	SELL Open market or private sale	$39,609 $3.57 p/Share	11,095 Reduced 3.31%	323,764 Common Stock
Aug 16 2022	SELL Open market or private sale	$9,549 $4.76 p/Share	2,006 Reduced 0.6%	334,859 Common Stock
Aug 15 2022	BUY Grant, award, or other acquisition	-	165,938 Added 33.0%	336,865 Common Stock
May 16 2022	SELL Open market or private sale	$23,072 $3.95 p/Share	5,841 Reduced 3.31%	170,427 Common Stock
May 15 2022	BUY Grant, award, or other acquisition	-	10,950 Added 5.85%	176,268 Common Stock
Feb 16 2022	SELL Open market or private sale	$25,875 $10.95 p/Share	2,363 Reduced 1.41%	165,318 Common Stock
Dec 16 2021	BUY Grant, award, or other acquisition	-	21,200 Added 11.22%	167,681 Common Stock
Nov 16 2021	SELL Open market or private sale	$88,712 $13.16 p/Share	6,741 Reduced 4.41%	145,981 Common Stock
Nov 15 2021	BUY Grant, award, or other acquisition	-	14,900 Added 8.89%	152,722 Common Stock
Aug 16 2021	SELL Open market or private sale	$184,478 $13.83 p/Share	13,339 Reduced 8.82%	137,822 Common Stock
May 17 2021	SELL Open market or private sale	$245,055 $18.3 p/Share	13,391 Reduced 8.14%	151,161 Common Stock
Feb 16 2021	SELL Open market or private sale	$261,841 $22.37 p/Share	11,705 Reduced 6.64%	164,552 Common Stock
Jan 28 2021	SELL Open market or private sale	$1,396,500 $18.62 p/Share	75,000 Reduced 29.85%	176,257 Common Stock
Jan 28 2021	BUY Exercise of conversion of derivative security	$660,000 $8.8 p/Share	75,000 Added 22.99%	251,257 Common Stock
Dec 18 2020	BUY Grant, award, or other acquisition	-	16,000 Added 8.32%	176,257 Common Stock
Nov 16 2020	SELL Open market or private sale	$202,754 $16.93 p/Share	11,976 Reduced 6.97%	159,757 Common Stock

JBT

Jillian B. Thomsen

Chief Financial Officer

San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NKTR shares.

Notify only if

Value

Insider Trading

Get notified when an Nektar Therapeutics insider buys or sells NKTR shares.

Notify only if

Operation

Value

Type

News

Receive news related to NEKTAR THERAPEUTICS

Track Activities on NKTR

Account